FNTB
Protein farnesyltransferase subunit beta
Also known as: FNTB_HUMAN, FPTB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49356
- Gene
- FNTB
- Ensembl
- ENSG00000257365
- Chromosome
- 14
- Canonical length
- 437 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Centrosome
OverviewNCBI Gene
This locus represents naturally occurring read-through transcription between the neighboring CHURC1 (churchill domain containing 1) and FNTB (farnesyltransferase, CAAX box, beta) on chromosome 14. The read-through transcript produces a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
437 residues, UniProt reviewed canonical sequence.
>P49356|FNTB
1 MASPSSFTYY CPPSSSPVWS EPLYSLRPEH ARERLQDDSV ETVTSIEQAK VEEKIQEVFS
61 SYKFNHLVPR LVLQREKHFH YLKRGLRQLT DAYECLDASR PWLCYWILHS LELLDEPIPQ
121 IVATDVCQFL ELCQSPEGGF GGGPGQYPHL APTYAAVNAL CIIGTEEAYD IINREKLLQY
181 LYSLKQPDGS FLMHVGGEVD VRSAYCAASV ASLTNIITPD LFEGTAEWIA RCQNWEGGIG
241 GVPGMEAHGG YTFCGLAALV ILKRERSLNL KSLLQWVTSR QMRFEGGFQG RCNKLVDGCY
301 SFWQAGLLPL LHRALHAQGD PALSMSHWMF HQQALQEYIL MCCQCPAGGL LDKPGKSRDF
361 YHTCYCLSGL SIAQHFGSGA MLHDVVLGVP ENALQPTHPV YNIGPDKVIQ ATTYFLQKPV
421 PGFEELKDET SAEPATDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FNTB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 136 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 136 nTPM
- midbrain: 34 nTPM
- skeletal muscle: 22 nTPM
- tongue: 19 nTPM
- esophagus: 17 nTPM
- skin: 17 nTPM
Single-cell type
- platelets: 132 nCPM
- oligodendrocytes: 112 nCPM
- bergmann glia: 52 nCPM
- astrocytes: 51 nCPM
- esophageal apical cells: 50 nCPM
- choroid plexus epithelial cells: 49 nCPM
Immune cell
- basophil: 22 nTPM
- classical monocyte: 13 nTPM
- eosinophil: 12 nTPM
- intermediate monocyte: 9.9 nTPM
- MAIT T-cell: 9.5 nTPM
- myeloid DC: 7.3 nTPM
Brain region
- white matter: 128 nTPM
- medulla oblongata: 100 nTPM
- cerebellum: 67 nTPM
- pons: 63 nTPM
- spinal cord: 58 nTPM
- midbrain: 52 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.08
- gnomAD missense Z
- 1.38
- DepMap mean gene effect
- -0.68
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- lipid metabolic process
- positive regulation of cell cycle
- positive regulation of cell population proliferation
- protein farnesylation
- regulation of microtubule-based movement
Molecular functions
- acetyltransferase activator activity
- enzyme binding
- peptide binding
- protein farnesyltransferase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FNTB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FNTB as an antibody target. Whether an autoantibody or antibody against FNTB could matter depends on whether native FNTB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FNTB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FNTB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...